During the past decade, Ilsan Paik hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ilsan Paik hospital" #1 collaborator was "Asan Medical Center" with 1 trials as a collaborator, "Samsung Medical Center" with 1 trials as a collaborator, "Seoul National University Hospital" with 1 trials as a collaborator and "Severance Hospital" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Ilsan Paik hospital" are "Atherosclerosis" (1 trials), "Breast Cancer" (1 trials), "Cardiovascular Diseases" (1 trials) and "Coronary Artery Disease" (1 trials). Many other conditions were trialed in "Ilsan Paik hospital" in a lesser frequency.

Most popular intervention types in "Ilsan Paik hospital" are "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Letrozole" (1 trials) and "Trastuzumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ilsan Paik hospital" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ilsan Paik hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Ilsan Paik hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ilsan Paik hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".